Analystreport

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

EyePoint Pharmaceuticals, Inc.  (EYPT) 
Last eyepoint pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report